New Discovery About The Formation Of New Brain Cells
Main Category: Neurology / NeuroscienceAlso Included In: Stem Cell Research; Biology / Biochemistry
Article Date: 25 Nov 2009 - 0:00 PDT
| Patient / Public: | ![]() |
4.29 (7 votes) |
| Healthcare Prof: | ![]() |
4 (3 votes) |
| Article Opinions: | 1 posts |
The generation of new nerve cells in the brain is regulated by a peptide known as C3a, which directly affects the stem cells' maturation into nerve cells and is also important for the migration of new nerve cells through the brain tissue, reveals new research from the Sahlgrenska Academy published in the journal Stem Cells.
Although the research has been carried out using mice and cultured cells, it could lead to a new medicine for human beings, which could be given to patients who have had a stroke or other disorders that damage or destroy the nerve cells.
"Our research findings show that it could be possible to use molecules that are similar to the peptide C3a to boost the formation of nerve cells and stimulate the replacement of nerve cells lost due to injury or illness," says senior lecturer Marcela Pekna who headed the research group at the Sahlgrenska Academy.
The peptide C3a is generated through the activation of the complement system, a group of proteins in the blood that is essential for the body's immune defence.
"Our research group was the first in the world to show that the complement system also plays an important role in the repair and regeneration of the brain," says Pekna. "This was a surprising discovery that opened up a whole new field of research."
New Nerve Cells
New nerve cells are formed in the brain throughout our lives. The brain's stem cells are formed in the hippocampus and the subventricular zone, an area next to the fluid-filled cavities (lateral ventricles). Stem cells from the subventricular zone mature into nerve cells in the olfactory bulb, but can also migrate out into the brain to replace nerve cells that have been damaged or destroyed. By finding out more about how new nerve cells are formed and what controls their migration, stem cell researchers hope to find new ways of treating stroke, Parkinson's disease and other disorders that result from the nerve cells failing to function as they should.
Title of the article: Complement-derived Anaphylatoxin C3a Regulates In Vitro Differentiation and Migration of Neural Progenitor Cells
Authors: Noriko Shinjyo, Anders Ståhlberg, Mike Dragunow, Milos Pekny, Marcela Pekna
Source: Marcela Pekna
University of Gothenburg
Visit our neurology / neuroscience section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/172012.php>
APA
http://www.medicalnewstoday.com/releases/172012.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Mrs
posted by Trudy Weichers on 29 Nov 2009 at 10:53 pmMy husband had a stroke five years ago and we are trying to get as much information as possible on ways to regenerate the brain so he won't have so much trouble with pain which has to do with damaged nerve cells. Also interested in clinical studies. Thank you
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




